Unilever defends £50bn bid for GSK consumer health unit
Published
Analysts express concern over potential deal as GSK investors hold out for £60bn
Full ArticlePublished
Analysts express concern over potential deal as GSK investors hold out for £60bn
Full ArticlePlan to buy consumer health business has faced fierce opposition from shareholders
Investors push for higher price or spin-off after rejecting Unilever’s £50bn offer